189089-90-5

Basic information

• Product Name: 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid
• Synonyms: 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid;1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid;1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 1-(phenylsulfonyl)-;1-(Phenylsulphonyl)-7-azaindole-2-carboxylic acid;1-(phenylsulfonyl)-7-azaindole-2-carboxylic acid
• CAS NO: 189089-90-5
• Molecular Formula: C₁₄H₁₀N₂O₄S
• Molecular Weight: 302.3052
• Product Categories: Heterocycle-Pyridine series
• Mol File: 189089-90-5.mol

Chemical Properties

• Boiling Point: 587.064°C at 760 mmHg
• Flash Point: 308.846°C
• Appearance: /
• Density: 1.49g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.694
• CAS DataBase Reference: 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid(189089-90-5)
• EPA Substance Registry System: 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid(189089-90-5)

Safety Data

• Hazardous Substances Data: 189089-90-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid is used as a key intermediate in the synthesis of pharmaceutical compounds, specifically for the development of potential anti-cancer and anti-inflammatory drugs. Its unique molecular structure and functional groups make it a valuable building block in the creation of diverse organic compounds and pharmaceuticals, contributing to the advancement of novel therapeutic agents.
Used in Organic Synthesis:
1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid is employed as a versatile building block in organic synthesis, allowing for the construction of a wide range of chemical entities. Its presence in the synthesis process can lead to the development of new compounds with potential applications in various fields, such as materials science, agrochemistry, and specialty chemicals.

InChI:InChI=1/C14H10N2O4S/c17-14(18)12-9-10-5-4-8-15-13(10)16(12)21(19,20)11-6-2-1-3-7-11/h1-9H,(H,17,18)

Upstream product

• 189089-91-6 1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-2-carbaldehyde 
• 98-09-9 benzenesulfonyl chloride 
• 271-63-6 7-Azaindole 
• 124-38-9 carbon dioxide 
• 143141-23-5 1-benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 1272003-73-2 C₁₅H₉N₃O₂ 
• 1239864-87-9 C₁₄H₁₁N₃O 
• 1239864-86-8 N-phenyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide 
• 1272003-81-2 C₁₈H₁₈N₄O₄S 
• 221675-35-0 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester 
• 1272003-83-4 C₁₈H₁₈N₄O₃S₂ 
• 1272003-79-8 C₂₄H₂₃N₅O₃S 
• 136818-50-3 7-azaindole-2-carboxylic acid 

Relevant articles and documents

Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors

From four molecules, inspired by the structural features of fascaplysin, with an interesting potential to inhibit cyclin-dependent kinases (CDKs), we designed a new series of tri-heterocyclic derivatives based on 1H-pyrrolo[2,3-b]pyridine (7-azaindole) an

Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors

Several thalidomide analogues were synthesized and compared to thalidomide and its more active analogue, lenalidomide, for their ability to inhibit the production of the pro-inflammatory cytokine tumour necrosis factor (TNF)-α and interleukin (IL)-6 by LPS-activated peripheral blood mononuclear cells (PBMCs). Among these compounds, two analogues containing sulfonyl group displayed interesting downregulation of TNF-α and IL-6 production.

AZAINDOLE CARBOXAMIDES

The invention relates to azaindole derivatives of general formula (I), wherein X represents a group of general formula (X1). Said compounds have a therapeutic potential in the treatment of diseases that are accompanied by an impaired dopamine metabolism a

Synthesis of 2-substituted-1H-pyrrolo[2,3-b]pyridines: Preparation of 7-azaolivacine analogue and 7-azaindolopyridopyrimidine derivatives

2-Substituted-1H-pyrrolo(2,3-b]pyridines have been prepared from 7-azaindole by lithiation followed by addition of various electrophiles. A 7-azaolivacine analogue and pyrido[3'2':4,5]pyrrolo[1,2-c]pyrido[3,2-d]pyrimidine have also been prepared.